4.3 Article

Lung and Thymic Carcinoids

Journal

Publisher

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.ecl.2018.04.011

Keywords

Carcinoid; Lung carcinoid; Lung neuroendocrine; Thymic neuroendocrine; Thymic carcinoid

Funding

  1. GSK
  2. Merrimack
  3. AbbVie
  4. BMS
  5. AstraZeneca
  6. Novartis
  7. Kyowa

Ask authors/readers for more resources

Carcinoids of the lung and thymus are rare thoracic cancers. In general, lung carcinoid tumors have a favorable prognosis, particularly when diagnosed at an early stage and treated with surgical resection. Thymic neuroendocrine tumors may be associated with multiple endocrine neoplasia-1 syndrome, tend to have a more aggressive natural history, and relatively frequently secrete ectopic adrenocorticotropic hormone.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available